113 filings
Page 2 of 6
8-K
uuti5thunyvc39js9c
7 Dec 23
Departure of Directors or Certain Officers
8:58am
PRE 14A
305bgt8k pipzeojxfm
21 Nov 23
Preliminary proxy
4:57pm
8-K
4m88i11h6qg15rhjzff
17 Nov 23
Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
7:30am
8-K
6qeu2h0pq5488cwz6n8
17 Nov 23
Virpax Pharmaceuticals Announces Leadership Transition
7:15am
8-K
tzqrx2z3px4t0tly
16 Nov 23
Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments
4:51pm
NT 10-Q
9kbdkf1w5z 3sxzx
15 Nov 23
Notice of late quarterly filing
3:03pm
8-K
3fad64ml kh
11 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
8-K
qo42 zl4n07jfwhum
5 Sep 23
Virpax Pharmaceuticals Updates on Litigation
9:28am
8-K
vusp 2v2gxbho7iod
16 Aug 23
Departure of Directors or Certain Officers
5:00pm
8-K
oqyxt
14 Aug 23
Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments
9:05am
8-K
37k5fxi4kzmd
26 Jul 23
Submission of Matters to a Vote of Security Holders
4:10pm
DEFA14A
zox1xqv09fz
22 Jun 23
Additional proxy soliciting materials
8:14am
8-K
2o26h0a60jk7zop
21 Jun 23
Virpax Pharmaceuticals Announces CFO Transition
4:16pm
8-K
998r3cr0
7 Jun 23
Departure of Directors or Certain Officers
4:15pm
ARS
8ljvxhmnay 4k1
7 Jun 23
Annual report to shareholders
4:11pm
8-K
h170p1zctj39p
12 May 23
Virpax Pharmaceuticals Reports 2023 First Quarter Results and Recent Developments
4:10pm